Pro-inflammatory M1 macrophages promote Osteogenesis by mesenchymal stem cells via the COX-2-prostaglandin E2 pathway

被引:166
|
作者
Lu, Laura Y. [1 ]
Loi, Florence [1 ]
Nathan, Karthik [1 ]
Lin, Tzu-hua [1 ]
Pajarinen, Jukka [1 ]
Gibon, Emmanuel [1 ,2 ]
Nabeshima, Akira [1 ]
Cordova, Luis [1 ,3 ]
Jamsen, Eemeli [1 ,4 ,5 ]
Yao, Zhenyu [1 ]
Goodman, Stuart B. [1 ,6 ]
机构
[1] Stanford Univ, Dept Orthoped Surg, Stanford, CA 94305 USA
[2] Univ Paris 07, CNRS, UMR 7052, Lab Biomecan & Biomat Osteoarticulaires,Fac Med, Paris, France
[3] Univ Chile, Dept Oral & Maxillofacial Surg, Santiago, Chile
[4] Univ Helsinki, Clinicum, Dept Med, Helsinki, Finland
[5] Helsinki Univ Hosp, Helsinki, Finland
[6] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA
基金
美国国家卫生研究院;
关键词
polarized macrophages; mesenchymal stem cells; osteogenesis; fracture healing; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; DOWN-REGULATION; BONE; CYCLOOXYGENASE-2; DIFFERENTIATION; INDUCTION; COX-2; POLARIZATION; INHIBITION; PARTICLES;
D O I
10.1002/jor.23553
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Bone fractures are among the most common orthopaedic problems that affect individuals of all ages. Immediately after injury, activated macrophages dynamically contribute to and regulate an acute inflammatory response that involves other cells at the injury site, including mesenchymal stem cells (MSCs). These macrophages and MSCs work in concert to modulate bone healing. In this study, we co-cultured undifferentiated M0, pro-inflammatory M1, and anti-inflammatory M2 macrophages with primary murine MSCs in vitro to determine the cross-talk between polarized macrophages and MSCs and their effects on osteogenesis. After 4 weeks of co-culture, MSCs grown with macrophages, especially M1 macrophages, had enhanced bone mineralization compared to MSCs grown alone. The level of bone formation after 4 weeks of culture was closely associated with prostaglandin E2 (PGE2) secretion early in osteogenesis. Treatment with celecoxib, a cyclooxygenase-2 (COX-2) selective inhibitor, significantly reduced bone mineralization in all co-cultures but most dramatically in the M1-MSC co-culture. We also found that the presence of macrophages reduced the secretion of osteoprotegerin (OPG), the decoy RANKL receptor, suggesting that macrophages may indirectly modulate osteoclast activity in addition to enhancing bone formation. Taken together, these findings suggest that an initial pro-inflammatory phase modulated by M1 macrophages promotes osteogenesis in MSCs via the COX-2-PGE2 pathway. Understanding the complex interactions between macrophages and MSCs provide opportunities to optimize bone healing and other regenerative processes via modulation of the inflammatory response. This study provides one possible biological mechanism for the adverse effects of non-steroidal anti-inflammatory drugs on fracture healing and bone regeneration. (c) 2017 Orthopaedic Research Society. Published by Wiley Periodicals, Inc. J Orthop Res 35:2378-2385, 2017.
引用
收藏
页码:2378 / 2385
页数:8
相关论文
共 50 条
  • [41] Activation of the EP4 prostanoid receptor induces prostaglandin E2 and pro-inflammatory cytokine production in human airway epithelial cells
    Li, Tiesong
    Qi, Jiansong
    Cowley, Elizabeth A.
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2011, 24 (01) : 42 - 48
  • [42] Inactivation of CES1 Blocks Prostaglandin D2 Glyceryl Ester Catabolism in Monocytes/Macrophages and Enhances Its Anti-inflammatory Effects, Whereas the Pro-inflammatory Effects of Prostaglandin E2 Glyceryl Ester Are Attenuated
    Scheaffer, Hannah L.
    Borazjani, Abdolsamad
    Szafran, Brittany N.
    Ross, Matthew K.
    ACS OMEGA, 2020, 5 (45): : 29177 - 29188
  • [43] Prostaglandin E2 Indicates Therapeutic Efficacy of Mesenchymal Stem Cells in Experimental Traumatic Brain Injury
    Kota, Daniel J.
    Prabhakara, Karthik S.
    Toledano-Furman, Naama
    Bhattarai, Deepa
    Chen, Qingzheng
    DiCarlo, Bryan
    Smith, Philippa
    Triolo, Fabio
    Wenzel, Pamela L.
    Cox, Charles S.
    Olson, Scott D.
    STEM CELLS, 2017, 35 (05) : 1416 - 1430
  • [44] ANTIGENS CHARACTERISTIC OF M2 TYPE PRO-INFLAMMATORY MACROPHAGES ARE PRESENT ON GBM TUMOR CELLS
    Debinski, Waldemar
    Choi, Young A.
    Gibo, Denise M.
    NEURO-ONCOLOGY, 2013, 15 : 63 - 63
  • [45] Effects of prostaglandin E2 and D2 on cell proliferation and osteogenic capacity of human mesenchymal stem cells
    Ern, C.
    Frasheri, I
    Berger, T.
    Kirchner, H. G.
    Heym, R.
    Hickel, R.
    Folwaczny, M.
    PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS, 2019, 151 : 1 - 7
  • [46] Regulation of bone morphogenetic protein-2 expression by endogenous prostaglandin E2 in human mesenchymal stem cells
    Arikawa, T
    Omura, K
    Morita, I
    JOURNAL OF CELLULAR PHYSIOLOGY, 2004, 200 (03) : 400 - 406
  • [47] IFN-γ/SrBG composite scaffolds promote osteogenesis by sequential regulation of macrophages from M1 to M2
    Luo, Man
    Zhao, Fujian
    Liu, Lu
    Yang, Zhen
    Tian, Ting
    Chen, Xiaoyu
    Cao, Xiaodong
    Chen, Dafu
    Chen, Xiaofeng
    JOURNAL OF MATERIALS CHEMISTRY B, 2021, 9 (07) : 1867 - 1876
  • [48] Pro-inflammatory macrophages promote prostate cancer initiation and progression via NOX2-mediated oxidative stress
    Jones, Kia J.
    Bryant, Latoya K.
    Hinton, Cimona V.
    CANCER RESEARCH, 2015, 75
  • [49] Mesenchymal Stem Cells Attenuates Hirschsprung diseases - Associated Enterocolitis by Reducing M1 Macrophages Infiltration via COX-2 Dependent Mechanism (vol 59, pg 1498, 2024)
    Meng, Xinyao
    Xiao, Jun
    Wang, Jing
    Sun, Minxian
    Chen, Xuyong
    Wu, Luyao
    Chen, Ke
    Li, Zejian
    Feng, Chenzhao
    Zhuansun, Didi
    Yang, Jixin
    Wu, Xiaojuan
    Yu, Donghai
    Li, Wei
    Niu, Yonghua
    He, Ying
    Wei, Mingfa
    Chen, Feng
    Xiong, Bo
    Feng, Jiexiong
    Zhu, Tianqi
    JOURNAL OF PEDIATRIC SURGERY OPEN, 2025, 9
  • [50] Meloxicam inhibits prostaglandin E2 generation via cyclooxygenase 2 in the inflammatory site but not that via cyclooxygenase 1 in the stomach
    Ogino, K
    Hatanaka, K
    Kawamura, M
    Ohno, T
    Harada, Y
    PHARMACOLOGY, 2000, 61 (04) : 244 - 250